loading

Soleno Therapeutics Inc Stock (SLNO) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
68.76%
23.48
13.91 10.38 8.623 8.469
Depreciation and Amortization
0.20%
0.49
0.489 0.49 0.489 0.49
Operating Income/Loss
68.76%
-23.48
-13.91 -10.38 -8.623 -8.469
Nonoperating Income/Loss
20.54%
2.077
2.614 -0.479 0.148 0.113
Income/Loss From Continuing Operations Before Tax
89.43%
-21.40
-11.30 -10.86 -8.475 -8.356
Income/Loss From Continuing Operations After Tax
89.43%
-21.40
-11.30 -10.86 -8.475 -8.356
Net Income/Loss
89.43%
-21.40
-11.30 -10.86 -8.475 -8.356
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
498.59%
36.21
6.0489 11.44 10.42 9.4474
Diluted Average Shares
498.59%
36.21
6.0489 11.44 10.42 9.4474
Basic Earnings Per Share
303.45%
-0.59
0.29 -0.95 -0.81 -0.88
Diluted Earnings Per Share
303.45%
-0.59
0.29 -0.95 -0.81 -0.88
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.94
price down icon 1.35%
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Cap:     |  Volume (24h):